Remus Pharmaceuticals Limited IPO
Remus Pharmaceuticals Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹1150–₹1229 per share. The stock debuted at ₹1711.25, delivering a listing gain of 39.2%. The IPO had a lot size of ₹100 shares and a minimum investment of ₹1,22,900.
Remus Pharmaceuticals Limited IPO
- IPO Dates
- May 17, 2023 – May 19, 2023
- Price band
- ₹1150-1229 per equity share
- Minimum Investment
- ₹1,22,900
- Issue size
- Fresh Issue : 388,000 shares(aggregating up to ₹47.69 Cr)
- Lot size
- 100
- Allotment Date
- May 24, 2023
- Listing
- May 29, 2023
- Listing At
- NSE SME
IPO timeline
-
May 17, 2023
Open Date
Completed
-
May 19, 2023
Close Date
Completed
-
May 24, 2023
Allotment Date
Completed
-
May 29, 2023
Listing Date
Completed
Remus Pharmaceuticals Limited IPO Essentials
Remus Pharmaceuticals Limited IPO Details
Remus Pharmaceuticals Limited IPO is priced at ₹1150-1229 per share with a total issue size of Fresh Issue : 388,000 shares(aggregating up to ₹47.69 Cr). The IPO has a lot size of 100 shares and is listed on NSE SME.
- Issue price
- ₹1150-1229 per equity share
- Lot size
- 100 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- Fresh Issue : 388,000 shares(aggregating up to ₹47.69 Cr)
- Listing at
- NSE SME
- List price
- 1711.25
- Listing date
- Registrar
- Link Intime India Private Ltd
- Lead manager
-
Beeline Capital Advisors Pvt Ltd
Remus Pharmaceuticals Limited IPO Analytics
Remus Pharmaceuticals Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Remus Pharmaceuticals Limited IPO Subscription Status
Remus Pharmaceuticals Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 347,040 / 1,179,242 | 1,944,118 | 3,470,400 |
|
Day 1
17-05-23 06:00 PM
|
(0.00 / 2.85) x | 2.85 x | 1.43 x |
|
Day 2
18-05-23 06:00 PM
|
(1.48 / 12.25) x | 10.79 x | 6.36 x |
|
Day 3
19-05-23 06:00 PM
|
(10.75 / 229.31) x | 49.81 x | 57.21 x |
Remus Pharmaceuticals Limited Valuations
Returns
- RoNW
- N/A%
Remus Pharmaceuticals Limited Financials( In Lakhs)
| 30-Dec-22 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
|---|---|---|---|---|
| Assets | 3,352.96 | 1,590.93 | 1,104.96 | 530.36 |
| Revenue | 3,361.20 | 2,543.71 | 1,922.45 | 1,276.89 |
| Profit After Tax | 643.90 | 338.57 | 102.58 | 81.16 |
Remus Pharmaceuticals Limited Company & Offer Insights
About Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.
The product offerings of the company can be classified into two major categories:
APIs: Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.
Finished Pharmaceutical Formulations: Finished pharmaceutical formulations are therapeutic drugs available in different dosage forms.
The product portfolio consists of 429 products, as on January 31, 2023. They operate under different brand names across the globe. As on January 31, 2023, the company has 295 products registered in a total of 13 countries. As on January 31, 2023, a total of 134 ;products are under the process of registration in 16 countries.
As on January 31, 2023, Remus Pharmaceuticals had business-to-business supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply.
The company has cultivated strong and dependable customer relationships and its clients are spread in more than 20 countries. These clients range from Generic distributors, regional distributors, and Multinational distributors to Hospitals and Clinics.
Remus Pharmaceuticals Limited Promoter(s)
Mr. Arpit Deepakkumar Shah, Ms. Roma Vinodbhai Shah, Mr. Swapnil Jatinbhai Shah, Mrs. Anar Swapnil Shah are the company's promoters of Remus Pharmaceuticals Limited.
Remus Pharmaceuticals Limited IPO Issue Objectives
- •
- To Meet Working Capital Requirements
- •
- Funding investments for acquisitions and general corporate purposes
- •
- To meet Public Issue Expenses
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Remus Pharmaceuticals Limited IPO is a book-built IPO worth ₹Fresh Issue : 388,000 shares(aggregating up to ₹47.69 Cr). The price band is ₹1150–₹1229 per share. The IPO opens on May 17, 2023 and closes on May 19, 2023. It will be listed on NSE SME Platform. Link Intime India Private Ltd is the registrar.
The price band of Remus Pharmaceuticals Limited IPO is ₹1150 to ₹1229 per share.
The lot size of Remus Pharmaceuticals Limited IPO is 100 shares.
The minimum investment for Remus Pharmaceuticals Limited IPO is approximately ₹1,22,900 based on the upper price band .
Remus Pharmaceuticals Limited IPO opens on May 17, 2023 and closes on May 19, 2023.
The allotment date of Remus Pharmaceuticals Limited IPO is May 24, 2023.
Remus Pharmaceuticals Limited IPO is expected to be listed on May 29, 2023, on NSE SME Platform.
Remus Pharmaceuticals Limited IPO valuation snapshot: P/E N/A, EPS ₹N/A/-, P/B N/A, RoNW N/A%, and market cap N/A.
To apply for Remus Pharmaceuticals Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Remus Pharmaceuticals Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Remus Pharmaceuticals Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Remus Pharmaceuticals Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Remus Pharmaceuticals Limited IPO allotment status on IPO Ji for quick and easy access.